Shares of Novavax fell 6.12% to $207.95 at 14:23 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is dropping 1% to $13,774.94, following last session’s downward trend, This seems, up until now, a somewhat rough trend trading session today.
Novavax’s last close was $221.50, 59.50% below its 52-week high of $331.68.
Novavax’s sales growth is 8542.9% for the present quarter and 1971.3% for the next. The company’s growth estimates for the current quarter is a negative 356.9% and positive 930% for the next.
Year-on-year quarterly revenue growth grew by 3072.2%, now sitting on 475.6M for the twelve trailing months.
Novavax’s Stock Yearly Top and Bottom Value
Novavax’s stock is valued at $207.95 at 14:23 EST, way below its 52-week high of $331.68 and way higher than its 52-week low of $14.38.
Novavax’s Moving Average
Novavax’s value is under its 50-day moving average of $210.81 and way above its 200-day moving average of $149.03.
More news about Novavax.